insulin--(b1)-des-phe- and Glycosuria

insulin--(b1)-des-phe- has been researched along with Glycosuria* in 1 studies

Trials

1 trial(s) available for insulin--(b1)-des-phe- and Glycosuria

ArticleYear
[Treatment of diabetic patients with Optisulin-Depot CR in comparison with Depot-Insulin Hoechst klar CR--therapeutic progress?].
    Wiener medizinische Wochenschrift (1946), 1983, Jan-31, Volume: 133, Issue:2

    During a cross-over-study in 12 ambulant patients the effects of Optisulin -Depot CR in comparison to Depot-Insulin Hoechst klar CR were examined. After a period with Depot-Insulin Hoechst klar CR patients got Optisulin -Depot CR in the same dose and with the same diet. A week later patients took Depot-Insulin Hoechst klar CR once again. The different blood-sugar-curves corresponded to each other, but Optisulin -Depot CR showed more initial effect. The use of Depot-Insulin Hoechst klar CR is an advantage, because, Optisulin -Depot CR is neutral and no depot-substances are contained. Therefore, less allergic reactions are expected.

    Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Female; Glycosuria; Humans; Insulin; Ketone Bodies; Male; Middle Aged; Patient Education as Topic

1983